MMP2 and adenocarcinoma: Furthermore, the MMP-2 concentration was found to be statistically significantly higher in adenocarcinoma patients with the -735CC genotype (x ̄ = 157.69 ng/mL) than in adenocarcinoma patients with the -735CT genotype (x ̄ = 126.37 ng/mL, p = 0.013222).